Diabetes
The diabetes management space has long held a commanding lead as the most popular target for mobile health developers, according to a new blog post from Research2Guidance based on their mHealth App Developer Economics report, for which the research firm surveyed 5,000 developers.
Senseonics, a Germantown, Maryland-based company working on a longterm implantable continuous glucose monitor, has filed to go public with an IPO that, for now at least, is valued at $51.
Samsung and Medtronic are once again teaming up, this time to build mobile tools for patients using neuromodulation therapy, a treatment used in a number of chronic conditions including chronic pain, movement disorders, and incontinence.
When Kenneth Stack's son was diagnosed with Type 1 diabetes just before his fifth birthday, the doctor told Stack he was just a few years too early for a major medical breakthrough.
Voluntis's Diabeo app, not available in the United States
French medical app company Voluntis is partnering with Roche Pharma France, a subsidiary of Roche, to develop a mobile-based therapy for breast cancer.
Glooko and Joslin's HypoMap
Joslin Diabetes Center is running a small trial to pilot test a mobile health app and an online nutrition education platform for people with Type 1 diabetes, according to a ClinicalTrials.
An Oscar-branded Misfit Flash device.
Google and Novartis are working on two smart contact lenses, and news broke this week about both of them: A new patent application sheds light on how Google might power its glucose-sensing contact lens, just a week after partner Novartis told a Swiss newspaper it was on track for human trials in 2016 of an autofocus lens for presbyopia patients.
Welkin Health, a San Francisco-based population health management company that provides a combination of mobile, web, and telephone-based coaching programs, has raised $2 million in seed funding and announced its first major pilot, which is with Humana's Innovation Group.
New York City and Austin, Texas-based Informed Data Systems has raised $8 million for its One Drop mobile diabetes management platform.